Mather Group’s GoodRx Holdings GDRX Stock Holding History

Mather Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$14	–	1894
2024 Q2	$14	Buy	+2	New	+$15	﹤0.01%	2185

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mather Group's GDRX Position: Q3 2024 in Review

Mather Group sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 2 shares — an estimated $14 sold.

Mather Group first reported a position in GDRX in Q2 2024 and held it in 1 quarter. The position peaked at $14 in Q2 2024. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

Mather Group reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
Mather Group sold 2 GoodRx Holdings shares in Q3 2024, an estimated $14.
Mather Group first reported a position in GoodRx Holdings in Q2 2024 and held it in 1 quarter.
Mather Group's GoodRx Holdings position peaked at $14 in Q2 2024.
168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Mather Group's 13F filing for Q3 2024, filed 7 Oct 2024.